Table 2.
Whole sample |
White |
Black |
Native |
Asian |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1999 | 2019 | % change | 1999 | 2019 | % change | 1999 | 2019 | % change | 1999 | 2019 | % change | 1999 | 2019 | % change | |
Overall | 350.8 | 214.6 | −38.8% | 343.3 | 211.7 | −38.3% | 450.0 | 277.3 | −38.4% | 263.7 | 142.0 | −46.2% | 225.0 | 123.7 | −45.0% |
No Cancer | 338.0 | 208.4 | −38.3% | 330.6 | 205.4 | −37.9% | 434.3 | 270.1 | −37.8% | 256.2 | 138.1 | −46.1% | 217.0 | 120.6 | −44.4% |
Any cancer | 12.8 | 6.2 | −51.6% | 12.7 | 6.3 | −50.4% | 15.7 | 7.2 | −54.1% | 7.5 | 3.9 | −48.0% | 8.0 | 3.1 | −61.3% |
Breast | 1.7 | 0.7 | −58.8% | 1.7 | 0.7 | −58.8% | 1.9 | 1.0 | −47.4% | N/A | N/A | N/A | 0.8 | 0.3 | −62.5% |
Lung | 1.7 | 0.9 | −47.1% | 1.8 | 0.9 | −50% | 1.9 | 1.0 | −47.4% | N/A | 0.6 | N/A | 1.0 | 0.5 | −50.0% |
Colorectal | 1.9 | 0.6 | −68.4% | 1.9 | 0.6 | −68.4% | 2.2 | 0.7 | −68.2% | N/A | 0.7 | N/A | 1.0 | 0.3 | −70.0% |
Haematological | 1.7 | 1.0 | −41.2% | 1.7 | 1.0 | −41.2% | 1.6 | 1.0 | −37.5% | N/A | 0.6 | N/A | 0.9 | 0.6 | −33.3% |
Prostate | 2.5 | 1.0 | −60.0% | 2.4 | 1.0 | −58.3% | 4.1 | 1.7 | −58.5% | N/A | N/A | N/A | 1.5 | 0.4 | −73.3% |
Table 2 footnote*per 100,000 population.